We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
After introducing its Cancer Biomarkers activities at the AACR in April this year, Primagen Holding BV, a molecular diagnostics company, will exhibit its products in booth #4463 at the American Society of Clinical Oncology (ASCO) meeting being held in Atlanta, Georgia, from June 2-6.
Glenmark, an Indian pharmaceutical company that is focused on the manufacturing and marketing of formulation products, will today formally launch its operation in Jamaica.
Solutia Inc. today announced that its subsidiary, Solutia Europe SA/NV ("SESA"), has reached a definitive agreement to sell its Pharmaceutical Services business, comprised of CarboGen AG and AMCIS AG.
A team of scientists from the Nigerian Institute of Medical Research (NIMR) has approved Artequin, a new antimalarial formulation of the artemisinin-based combination therapy (ACT) that uses a combination of artesunate and mefloquine.
The European Medicines Agency has licensed the breast cancer drug Herceptin for use in the early stages of the disease by European regulators, the organization has announced.